Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
Titel:
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection
Auteur:
Zuckerman, Eli Gutierrez, Julio A. Dylla, Douglas E. de Ledinghen, Victor Muir, Andrew J. Gschwantler, Michael Puoti, Massimo Caruntu, Florin Slim, Jihad Nevens, Frederik Sigal, Samuel Cohen, Stanley Fredrick, Linda M. Pires dos Santos, Ana Gabriela Rodrigues Jr., Lino Dillon, John F.